Omega 3 Prescription Drug Market, Global Outlook and Forecast 2022-2028

August 2022 | 65 pages | ID: OC9F38CA92FEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Omega 3 Prescription Drug in Global, including the following market information:

Global Omega 3 Prescription Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Omega 3 Prescription Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vascepa Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Omega 3 Prescription Drug include Abbott, Amarin Pharmaceuticals Ireland Ltd., GSK plc (GlaxoSmithKline plc), Natrapharm, Inc. (Patriot Pharmaceutical Corp.), Viatris, Inc., Grupo Ferrer Internacional, S.A., Camber Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd. and Zydus Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Omega 3 Prescription Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Omega 3 Prescription Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Omega 3 Prescription Drug Market Segment Percentages, by Type, 2021 (%)

• Vascepa
• Lovaza
• Others

Global Omega 3 Prescription Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Omega 3 Prescription Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Omega 3 Prescription Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Omega 3 Prescription Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Omega 3 Prescription Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Omega 3 Prescription Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Amarin Pharmaceuticals Ireland Ltd.
• GSK plc (GlaxoSmithKline plc)
• Natrapharm, Inc. (Patriot Pharmaceutical Corp.)
• Viatris, Inc.
• Grupo Ferrer Internacional, S.A.
• Camber Pharmaceuticals, Inc.
• Dr. Reddy’s Laboratories Ltd.
• Zydus Group
• Hikma Pharmaceuticals PLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Omega 3 Prescription Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Omega 3 Prescription Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OMEGA 3 PRESCRIPTION DRUG OVERALL MARKET SIZE

2.1 Global Omega 3 Prescription Drug Market Size: 2021 VS 2028
2.2 Global Omega 3 Prescription Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Omega 3 Prescription Drug Players in Global Market
3.2 Top Global Omega 3 Prescription Drug Companies Ranked by Revenue
3.3 Global Omega 3 Prescription Drug Revenue by Companies
3.4 Top 3 and Top 5 Omega 3 Prescription Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Omega 3 Prescription Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Omega 3 Prescription Drug Players in Global Market
  3.6.1 List of Global Tier 1 Omega 3 Prescription Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Omega 3 Prescription Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Omega 3 Prescription Drug Market Size Markets, 2021 & 2028
  4.1.2 Vascepa
  4.1.3 Lovaza
  4.1.4 Others
4.2 By Type - Global Omega 3 Prescription Drug Revenue & Forecasts
  4.2.1 By Type - Global Omega 3 Prescription Drug Revenue, 2017-2022
  4.2.2 By Type - Global Omega 3 Prescription Drug Revenue, 2023-2028
  4.2.3 By Type - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Omega 3 Prescription Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Omega 3 Prescription Drug Revenue & Forecasts
  5.2.1 By Application - Global Omega 3 Prescription Drug Revenue, 2017-2022
  5.2.2 By Application - Global Omega 3 Prescription Drug Revenue, 2023-2028
  5.2.3 By Application - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Omega 3 Prescription Drug Market Size, 2021 & 2028
6.2 By Region - Global Omega 3 Prescription Drug Revenue & Forecasts
  6.2.1 By Region - Global Omega 3 Prescription Drug Revenue, 2017-2022
  6.2.2 By Region - Global Omega 3 Prescription Drug Revenue, 2023-2028
  6.2.3 By Region - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Omega 3 Prescription Drug Revenue, 2017-2028
  6.3.2 US Omega 3 Prescription Drug Market Size, 2017-2028
  6.3.3 Canada Omega 3 Prescription Drug Market Size, 2017-2028
  6.3.4 Mexico Omega 3 Prescription Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Omega 3 Prescription Drug Revenue, 2017-2028
  6.4.2 Germany Omega 3 Prescription Drug Market Size, 2017-2028
  6.4.3 France Omega 3 Prescription Drug Market Size, 2017-2028
  6.4.4 U.K. Omega 3 Prescription Drug Market Size, 2017-2028
  6.4.5 Italy Omega 3 Prescription Drug Market Size, 2017-2028
  6.4.6 Russia Omega 3 Prescription Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Omega 3 Prescription Drug Market Size, 2017-2028
  6.4.8 Benelux Omega 3 Prescription Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Omega 3 Prescription Drug Revenue, 2017-2028
  6.5.2 China Omega 3 Prescription Drug Market Size, 2017-2028
  6.5.3 Japan Omega 3 Prescription Drug Market Size, 2017-2028
  6.5.4 South Korea Omega 3 Prescription Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Omega 3 Prescription Drug Market Size, 2017-2028
  6.5.6 India Omega 3 Prescription Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Omega 3 Prescription Drug Revenue, 2017-2028
  6.6.2 Brazil Omega 3 Prescription Drug Market Size, 2017-2028
  6.6.3 Argentina Omega 3 Prescription Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Omega 3 Prescription Drug Revenue, 2017-2028
  6.7.2 Turkey Omega 3 Prescription Drug Market Size, 2017-2028
  6.7.3 Israel Omega 3 Prescription Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Omega 3 Prescription Drug Market Size, 2017-2028
  6.7.5 UAE Omega 3 Prescription Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Omega 3 Prescription Drug Major Product Offerings
  7.1.4 Abbott Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Amarin Pharmaceuticals Ireland Ltd.
  7.2.1 Amarin Pharmaceuticals Ireland Ltd. Corporate Summary
  7.2.2 Amarin Pharmaceuticals Ireland Ltd. Business Overview
  7.2.3 Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Major Product Offerings
  7.2.4 Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.2.5 Amarin Pharmaceuticals Ireland Ltd. Key News
7.3 GSK plc (GlaxoSmithKline plc)
  7.3.1 GSK plc (GlaxoSmithKline plc) Corporate Summary
  7.3.2 GSK plc (GlaxoSmithKline plc) Business Overview
  7.3.3 GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Major Product Offerings
  7.3.4 GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.3.5 GSK plc (GlaxoSmithKline plc) Key News
7.4 Natrapharm, Inc. (Patriot Pharmaceutical Corp.)
  7.4.1 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Corporate Summary
  7.4.2 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Business Overview
  7.4.3 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Major Product Offerings
  7.4.4 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.4.5 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Key News
7.5 Viatris, Inc.
  7.5.1 Viatris, Inc. Corporate Summary
  7.5.2 Viatris, Inc. Business Overview
  7.5.3 Viatris, Inc. Omega 3 Prescription Drug Major Product Offerings
  7.5.4 Viatris, Inc. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.5.5 Viatris, Inc. Key News
7.6 Grupo Ferrer Internacional, S.A.
  7.6.1 Grupo Ferrer Internacional, S.A. Corporate Summary
  7.6.2 Grupo Ferrer Internacional, S.A. Business Overview
  7.6.3 Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Major Product Offerings
  7.6.4 Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.6.5 Grupo Ferrer Internacional, S.A. Key News
7.7 Camber Pharmaceuticals, Inc.
  7.7.1 Camber Pharmaceuticals, Inc. Corporate Summary
  7.7.2 Camber Pharmaceuticals, Inc. Business Overview
  7.7.3 Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Major Product Offerings
  7.7.4 Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.7.5 Camber Pharmaceuticals, Inc. Key News
7.8 Dr. Reddy’s Laboratories Ltd.
  7.8.1 Dr. Reddy’s Laboratories Ltd. Corporate Summary
  7.8.2 Dr. Reddy’s Laboratories Ltd. Business Overview
  7.8.3 Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Major Product Offerings
  7.8.4 Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.8.5 Dr. Reddy’s Laboratories Ltd. Key News
7.9 Zydus Group
  7.9.1 Zydus Group Corporate Summary
  7.9.2 Zydus Group Business Overview
  7.9.3 Zydus Group Omega 3 Prescription Drug Major Product Offerings
  7.9.4 Zydus Group Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.9.5 Zydus Group Key News
7.10 Hikma Pharmaceuticals PLC
  7.10.1 Hikma Pharmaceuticals PLC Corporate Summary
  7.10.2 Hikma Pharmaceuticals PLC Business Overview
  7.10.3 Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Major Product Offerings
  7.10.4 Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
  7.10.5 Hikma Pharmaceuticals PLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Omega 3 Prescription Drug Market Opportunities & Trends in Global Market
Table 2. Omega 3 Prescription Drug Market Drivers in Global Market
Table 3. Omega 3 Prescription Drug Market Restraints in Global Market
Table 4. Key Players of Omega 3 Prescription Drug in Global Market
Table 5. Top Omega 3 Prescription Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Omega 3 Prescription Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Omega 3 Prescription Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Omega 3 Prescription Drug Product Type
Table 9. List of Global Tier 1 Omega 3 Prescription Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Omega 3 Prescription Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Omega 3 Prescription Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Omega 3 Prescription Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Omega 3 Prescription Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Omega 3 Prescription Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Omega 3 Prescription Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Omega 3 Prescription Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Omega 3 Prescription Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Omega 3 Prescription Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Omega 3 Prescription Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Omega 3 Prescription Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Omega 3 Prescription Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Omega 3 Prescription Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Omega 3 Prescription Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Omega 3 Prescription Drug Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Omega 3 Prescription Drug Product Offerings
Table 32. Abbott Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 33. Amarin Pharmaceuticals Ireland Ltd. Corporate Summary
Table 34. Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Product Offerings
Table 35. Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 36. GSK plc (GlaxoSmithKline plc) Corporate Summary
Table 37. GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Product Offerings
Table 38. GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 39. Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Corporate Summary
Table 40. Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Product Offerings
Table 41. Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 42. Viatris, Inc. Corporate Summary
Table 43. Viatris, Inc. Omega 3 Prescription Drug Product Offerings
Table 44. Viatris, Inc. Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 45. Grupo Ferrer Internacional, S.A. Corporate Summary
Table 46. Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Product Offerings
Table 47. Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 48. Camber Pharmaceuticals, Inc. Corporate Summary
Table 49. Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Product Offerings
Table 50. Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 51. Dr. Reddy’s Laboratories Ltd. Corporate Summary
Table 52. Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Product Offerings
Table 53. Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 54. Zydus Group Corporate Summary
Table 55. Zydus Group Omega 3 Prescription Drug Product Offerings
Table 56. Zydus Group Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)
Table 57. Hikma Pharmaceuticals PLC Corporate Summary
Table 58. Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Product Offerings
Table 59. Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Omega 3 Prescription Drug Segment by Type in 2021
Figure 2. Omega 3 Prescription Drug Segment by Application in 2021
Figure 3. Global Omega 3 Prescription Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Omega 3 Prescription Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Omega 3 Prescription Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Omega 3 Prescription Drug Revenue in 2021
Figure 8. By Type - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 12. US Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 16. Germany Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 24. China Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Omega 3 Prescription Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Omega 3 Prescription Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Viatris, Inc. Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Zydus Group Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)